NCT01746537 Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
| NCT ID | NCT01746537 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cleveland Clinic |
| Condition | Uveitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2012-06 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2012-06 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective, observational, case series investigating the feasibility of utilizing OCT scans of the anterior chamber of eyes with uveitis.
Eligibility Criteria
Inclusion Criteria: * All patients presenting to Cole Eye Institute with uveitis. Exclusion Criteria: * Inability to provide informed consent, including non-English speaking and cognitively/mentally impaired. * Severe corneal opacities preventing imaging of anterior chamber
Contact & Investigator
Sunil K Srivastava, M.D.
📞 216-636-2286
Sunil K Srivastva, MD
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT01746537 clinical trial?
This trial is open to participants of all sexes, studying Uveitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01746537 currently recruiting?
Yes, NCT01746537 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Cleveland Clinic to inquire about joining.
Where is the NCT01746537 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT01746537 clinical trial?
NCT01746537 is sponsored by The Cleveland Clinic. The principal investigator is Sunil K Srivastva, MD at The Cleveland Clinic. The trial plans to enroll 1,500 participants.